Banner

Clinuvel on Twitter

Read Related Blog Posts

Image

Lung, heart, mouth, nose, throat ...

In what has become something of a tradition in recent years, yet another country has used the new year to... Read more...

Image

Talking off the label – part th...

Allergan’s lawsuit filed against the FDA presents a relatively novel case in addressing the requirements of... Read more...

Image

Talking off the label - part two...

Following on from last week’s conversation, I left off with the issues surrounding the off-label... Read more...

Watch Related Videos

Part Four - The impact of Eryt...

Mikey's quality of life, like all patients with Erythropoietic Protoporphyria (EPP), is severely affected. Severe pain f... Watch now

Understanding Vitiligo - Cause...

Vitiligo is a common pigmentary disorder in which the pigment producing cells of the skin (melanocytes) are absent or do... Watch now

Part Three - Burning in shadow...

This is the third webcast in a series featuring Mikey, an Australian man with Erythropoietic Protoporphyria (EPP). You c... Watch now

JoomlaXTC K2 Content Wall - Copyright 2010 Monev Software LLC

SCENESSE Spotlight

SCENESSE® as a repigmentation therapy

Clinuvel is currently conducting two clinical trials to evaluate the efficacy of SCENESSE® as a combination therapy with narrowband ultraviolet B (NB-UVB) phototherapy compared to NB-UVB alone. The goal of these trials is to determine whether SCENESSE® will re... Read more

JoomlaXTC K2 Content Wall - Copyright 2010 Monev Software LLC